Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: fibroDAO®
Total 0 results
Nothing found
Sponsors and Collaborators
Amneal Pharmaceuticals Co. India Private Limited
Foshan Hospital of Traditional Chinese Medicine
Benxi Sixth People's Hospital
Pasi A. Janne, MD, PhD
Hewitt Foundation
Family Planning Association New South Wales
Liu Di
Scleroderma Clinical Trials Consortium (SCTC)
Gregand Innovations
Spotorno Foundation
Keith Heinzerling
Michigan Primary Care Association
Faculdade de Medicina do ABC
PLA 923 Hospital
Laboratorios Liconsa
City of Nokia
Mahmoud Fahd
Bruce Cree
Lodise & Lodise, LLC
Providence Care Hospital, Kingston, ON, Canada
View Full List
Medical Conditions
Urinary Incontinence in Geriatric Population
Advanced Intestinal Cancer
Human Mammary Carcinoma
Orthodontics, Corrective, Palatal Expansion Technique
Chronic Hepatitis C Genotype 1B
Gastric Submucosal Tumors
Cervical Spine Sprain
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Post-nasal Drip
Accidental Injuries
Venetoclax Combined With Azacitidine
Aneurysmal Subarachnoid Hemorrhage, Familial
Food IgE-mediated Allergy
Optim Lead Insulation Related Adverse Events
Piperacillin, Tazobactam Drug Combination
Recurrent Pleural Effusions
Infertilities
Primary Intestinal Lymphangiectasia
Musculoskeletal Injury
Primary Hypomagnesemia (Disorder)
View Full List
Drug Interventions
Peginterferon alfa-2a
SOF/VEL
Docetaxel Injection
Niacin
Viread 300Mg Tablet
Bempedoic Acid 180 MG Oral Tablet
Extremecare
DP001
Vitamin D
Cyclosporine 0.010%
PHA-022121 selected dose
YYC301-1 & YYC301-2 & YYC301-3
Ivermectin
Neem plus propylene glycol plus salicylic acid
ASP8825
Urokinase
SD-101
Experimental drug: ESK-001
2B3-101 50 mg/m2 every 3 weeks
Peg-Interferon alpha-2b
View Full List
CROs by country
Contract Research Organizations in Armenia
Contract Research Organizations in Belarus
Contract Research Organizations in Bulgaria
Contract Research Organizations in Cambodia
Contract Research Organizations in Djibouti
Contract Research Organizations in Dominican Republic
Contract Research Organizations in Finland
Contract Research Organizations in Mexico
Contract Research Organizations in Montenegro
Contract Research Organizations in Poland
Contract Research Organizations in Rwanda
Contract Research Organizations in Türkiye
Contract Research Organizations in Zambia
CRO list by country
CROs in Burundi
SGS
All CROs in Burundi
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe